These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

741 related articles for article (PubMed ID: 26642243)

  • 1. Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease.
    Zhou Q; Wang H; Schwartz DM; Stoffels M; Park YH; Zhang Y; Yang D; Demirkaya E; Takeuchi M; Tsai WL; Lyons JJ; Yu X; Ouyang C; Chen C; Chin DT; Zaal K; Chandrasekharappa SC; Hanson EP; Yu Z; Mullikin JC; Hasni SA; Wertz IE; Ombrello AK; Stone DL; Hoffmann P; Jones A; Barham BK; Leavis HL; van Royen-Kerkof A; Sibley C; Batu ED; Gül A; Siegel RM; Boehm M; Milner JD; Ozen S; Gadina M; Chae J; Laxer RM; Kastner DL; Aksentijevich I
    Nat Genet; 2016 Jan; 48(1):67-73. PubMed ID: 26642243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recruitment of A20 by the C-terminal domain of NEMO suppresses NF-κB activation and autoinflammatory disease.
    Zilberman-Rudenko J; Shawver LM; Wessel AW; Luo Y; Pelletier M; Tsai WL; Lee Y; Vonortas S; Cheng L; Ashwell JD; Orange JS; Siegel RM; Hanson EP
    Proc Natl Acad Sci U S A; 2016 Feb; 113(6):1612-7. PubMed ID: 26802121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A20 overexpression inhibits lipopolysaccharide-induced NF-κB activation, TRAF6 and CD40 expression in rat peritoneal mesothelial cells.
    Zou XL; Pei DA; Yan JZ; Xu G; Wu P
    Int J Mol Sci; 2014 Apr; 15(4):6592-608. PubMed ID: 24747594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downstream activation of NF-κB in the EDA-A1/EDAR signalling in Sjögren's syndrome and its regulation by the ubiquitin-editing enzyme A20.
    Sisto M; Barca A; Lofrumento DD; Lisi S
    Clin Exp Immunol; 2016 May; 184(2):183-96. PubMed ID: 26724675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel missense mutation in TNFAIP3 causes haploinsufficiency of A20.
    Jiang W; Deng M; Gan C; Wang L; Mao H; Li Q
    Cell Immunol; 2022 Jan; 371():104453. PubMed ID: 34808442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ABIN-1 binds to NEMO/IKKgamma and co-operates with A20 in inhibiting NF-kappaB.
    Mauro C; Pacifico F; Lavorgna A; Mellone S; Iannetti A; Acquaviva R; Formisano S; Vito P; Leonardi A
    J Biol Chem; 2006 Jul; 281(27):18482-8. PubMed ID: 16684768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Y14 positively regulates TNF-α-induced NF-κB transcriptional activity via interacting RIP1 and TRADD beyond an exon junction complex protein.
    Togi S; Shiga K; Muromoto R; Kato M; Souma Y; Sekine Y; Kon S; Oritani K; Matsuda T
    J Immunol; 2013 Aug; 191(3):1436-44. PubMed ID: 23817415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific recognition of linear polyubiquitin by A20 zinc finger 7 is involved in NF-κB regulation.
    Tokunaga F; Nishimasu H; Ishitani R; Goto E; Noguchi T; Mio K; Kamei K; Ma A; Iwai K; Nureki O
    EMBO J; 2012 Oct; 31(19):3856-70. PubMed ID: 23032187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in the genes coding for the NF-κB regulating factors IκBα and A20 are uncommon in nodular lymphocyte-predominant Hodgkin's lymphoma.
    Schumacher MA; Schmitz R; Brune V; Tiacci E; Döring C; Hansmann ML; Siebert R; Küppers R
    Haematologica; 2010 Jan; 95(1):153-7. PubMed ID: 19648161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular basis for the unique deubiquitinating activity of the NF-kappaB inhibitor A20.
    Lin SC; Chung JY; Lamothe B; Rajashankar K; Lu M; Lo YC; Lam AY; Darnay BG; Wu H
    J Mol Biol; 2008 Feb; 376(2):526-40. PubMed ID: 18164316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haploinsufficiency of A20 Due to Novel Mutations in TNFAIP3.
    He T; Huang Y; Luo Y; Xia Y; Wang L; Zhang H; Ling J; Yang J
    J Clin Immunol; 2020 Jul; 40(5):741-751. PubMed ID: 32514655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DSIF restricts NF-κB signaling by coordinating elongation with mRNA processing of negative feedback genes.
    Diamant G; Amir-Zilberstein L; Yamaguchi Y; Handa H; Dikstein R
    Cell Rep; 2012 Oct; 2(4):722-31. PubMed ID: 23041311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The RING ubiquitin E3 RNF114 interacts with A20 and modulates NF-κB activity and T-cell activation.
    Rodriguez MS; Egaña I; Lopitz-Otsoa F; Aillet F; Lopez-Mato MP; Dorronsoro A; Lobato-Gil S; Sutherland JD; Barrio R; Trigueros C; Lang V
    Cell Death Dis; 2014 Aug; 5(8):e1399. PubMed ID: 25165885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A20 negatively regulates T cell receptor signaling to NF-kappaB by cleaving Malt1 ubiquitin chains.
    Düwel M; Welteke V; Oeckinghaus A; Baens M; Kloo B; Ferch U; Darnay BG; Ruland J; Marynen P; Krappmann D
    J Immunol; 2009 Jun; 182(12):7718-28. PubMed ID: 19494296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Update on Autoinflammatory Diseases: Relopathies.
    Steiner A; Harapas CR; Masters SL; Davidson S
    Curr Rheumatol Rep; 2018 May; 20(7):39. PubMed ID: 29846841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant Low Expression of A20 in Tumor Necrosis Factor-α-stimulated SLE Monocytes Mediates Sustained NF-κB Inflammatory Response.
    Shi X; Qian T; Li M; Chen F; Chen Y; Hao F
    Immunol Invest; 2015; 44(5):497-508. PubMed ID: 26107748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proinflammatory mediators alter expression of nuclear factor kappa B-regulating deubiquitinases in sinonasal epithelial cells.
    Li P; Wang Y; Turner JH
    Int Forum Allergy Rhinol; 2015 Jul; 5(7):583-9. PubMed ID: 25907801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology.
    Vereecke L; Beyaert R; van Loo G
    Trends Immunol; 2009 Aug; 30(8):383-91. PubMed ID: 19643665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NF-kappaB suppression by the deubiquitinating enzyme Cezanne: a novel negative feedback loop in pro-inflammatory signaling.
    Enesa K; Zakkar M; Chaudhury H; Luong le A; Rawlinson L; Mason JC; Haskard DO; Dean JL; Evans PC
    J Biol Chem; 2008 Mar; 283(11):7036-45. PubMed ID: 18178551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-29 acts as a decoy in sarcomas to protect the tumor suppressor A20 mRNA from degradation by HuR.
    Balkhi MY; Iwenofu OH; Bakkar N; Ladner KJ; Chandler DS; Houghton PJ; London CA; Kraybill W; Perrotti D; Croce CM; Keller C; Guttridge DC
    Sci Signal; 2013 Jul; 6(286):ra63. PubMed ID: 23901138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.